The European Medicines Agency has approved jabs targeting both the original virus and the BA.1 subvariant of Omicron ahead of a feared Covid surge in the latter part of this year.
Moderna says Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.
British drug regulators have become the first in the world to authorise an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the Omicron variant.
The shots will become available next week, expanding the nation’s vaccination campaign to children as young as 6 months.
The vaccine can now be used as a booster following the two-dose Vaxzevria schedule or by those who have been vaccinated by an mRNA vaccine, such as the ones by Pfizer and BioNTech or Moderna.
US biotechnology company says it will permanently waive its Covid-19 vaccine patents for 92 low- and middle-income countries.
Covid-19 has infected more than 418M people and killed over 5.8M worldwide. Here are some of the latest coronavirus-related developments:
Covid-19 has infected more than 273M people and killed over 5.3M worldwide. Here are some of the latest coronavirus-related developments:
The mRNA Covid-19 vaccines provide the biggest impact, offer large antibody and generate a broad T-cell response, which may play a key role in longer-term protection, a new study finds.
The US-based pharmaceutical firm did not say where the production facility would be built but it envisages investing up to $500 million.
Though the vaccine was found to be safe, with no serious side effects, its efficacy in preventing HIV infection was just over 25 percent.
Coronavirus pandemic has killed more than 4.3 million people and infected over 207 million globally. Here are all the coronavirus-related developments for August 16:
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.